Literature DB >> 23518342

ROS links glucose metabolism to breast cancer stem cell and EMT phenotype.

Michael S Schieber1, Navdeep S Chandel.   

Abstract

Cancer stem cells display an epithelial-mesenchymal transition phenotype and are resistant to current therapies. In this issue of Cancer Cell, Dong and colleagues demonstrate that these phenotypes in basal-like breast cancer are promoted by a metabolic switch to glucose metabolism, resulting in decreased reactive oxygen species levels.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Year:  2013        PMID： 23518342     DOI： 10.1016/j.ccr.2013.02.021

Source DB:  PubMed          Journal:  Cancer Cell        ISSN： 1535-6108            Impact factor:   31.743


  51 in total

1.  Loss of fructose-1,6-bisphosphatase induces glycolysis and promotes apoptosis resistance of cancer stem-like cells: an important role in hexavalent chromium-induced carcinogenesis.

Authors:  Jin Dai; Yanli Ji; Wei Wang; Donghern Kim; Leonard Yenwong Fai; Lei Wang; Jia Luo; Zhuo Zhang
Journal:  Toxicol Appl Pharmacol       Date:  2017-06-15       Impact factor: 4.219

Review 2.  Multifaceted roles of HSF1 in cancer.

Authors:  Sufang Jiang; Kailing Tu; Qiang Fu; David C Schmitt; Lan Zhou; Na Lu; Yuhua Zhao
Journal:  Tumour Biol       Date:  2015-06-25

3.  p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.

Authors:  Xiaomei Qi; Ning Yin; Shao Ma; Adrienne Lepp; Jun Tang; Weiqing Jing; Bryon Johnson; Michael B Dwinell; Christopher R Chitambar; Guan Chen
Journal:  Stem Cells       Date:  2015-06-23       Impact factor: 6.277

Review 4.  Cancer stem cells, metabolism, and therapeutic significance.

Authors:  Mengqi Yang; Panpan Liu; Peng Huang
Journal:  Tumour Biol       Date:  2016-02-10

Review 5.  Metabolic control of cancer cell stemness: Lessons from iPS cells.

Authors:  Javier A Menendez
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

6.  SOD2 acetylation on lysine 68 promotes stem cell reprogramming in breast cancer.

Authors:  Chenxia He; Jeanne M Danes; Peter C Hart; Yueming Zhu; Yunping Huang; Andre Luelsdorf de Abreu; Joseph O'Brien; Angela J Mathison; Binwu Tang; Jonna M Frasor; Lalage M Wakefield; Douglas Ganini; Erich Stauder; Jacek Zielonka; Benjamin N Gantner; Raul A Urrutia; David Gius; Marcelo G Bonini
Journal:  Proc Natl Acad Sci U S A       Date:  2019-10-07       Impact factor: 11.205

7.  An integrative bioinformatics analysis identified miR-375 as a candidate key regulator of malignant breast cancer.

Authors:  Jiaxuan Liu; Ping Wang; Ping Zhang; Xinyu Zhang; Hang Du; Qiang Liu; Bo Huang; Caiyun Qian; Shuhua Zhang; Weifeng Zhu; Xiaohong Yang; Yingqun Xiao; Zhuoqi Liu; Daya Luo
Journal:  J Appl Genet       Date:  2019-08-01       Impact factor: 3.240

8.  Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.

Authors:  P-P Liu; J Liao; Z-J Tang; W-J Wu; J Yang; Z-L Zeng; Y Hu; P Wang; H-Q Ju; R-H Xu; P Huang
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

Review 9.  The tumor microenvironment: An irreplaceable element of tumor budding and epithelial-mesenchymal transition-mediated cancer metastasis.

Authors:  Hui Li; Fangying Xu; Si Li; Anjing Zhong; Xianwen Meng; Maode Lai
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

10.  Reactive oxygen species induce MMP12-dependent degradation of collagen 5 and fibronectin to promote the motility of human umbilical cord-derived mesenchymal stem cells.

Authors:  Seung Pil Yun; Sei-Jung Lee; Sang Yub Oh; Young Hyun Jung; Jung Min Ryu; Han Na Suh; Mi Ok Kim; Keon Bong Oh; Ho Jae Han
Journal:  Br J Pharmacol       Date:  2014-07       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.